NASDAQ:BCLI
$2.70
(
28.57%
)
Friday, 3rd Feb 2023
Brainstorm Cell Therapeutics Inc. Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $1.35 | $2.70 | Friday, 3rd Feb 2023 BCLI stock ended at $2.70. This is 28.57% more than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 29.19% from a day low at $2.09 to a day high of $2.70. |
| 90 days | $1.09 | $3.42 | |
| 52 weeks | $1.09 | $4.70 |
Historical Brainstorm Cell Therapeutics Inc. prices
| Date | Open | High | Low | Close | Volume |
| 2023-02-03 | $2.12 | $2.70 | $2.09 | $2.70 | 566 243 |
| 2023-02-02 | $2.02 | $2.14 | $1.95 | $2.10 | 259 576 |
| 2023-02-01 | $1.84 | $2.03 | $1.80 | $1.95 | 395 960 |
| 2023-01-31 | $1.75 | $1.88 | $1.72 | $1.82 | 245 681 |
| 2023-01-30 | $1.51 | $1.78 | $1.51 | $1.75 | 345 632 |
| 2023-01-27 | $1.56 | $1.57 | $1.49 | $1.52 | 151 954 |
| 2023-01-26 | $1.45 | $1.62 | $1.44 | $1.54 | 177 405 |
| 2023-01-25 | $1.43 | $1.47 | $1.40 | $1.45 | 30 378 |
| 2023-01-24 | $1.48 | $1.51 | $1.45 | $1.45 | 34 979 |
| 2023-01-23 | $1.50 | $1.52 | $1.43 | $1.50 | 59 487 |
| 2023-01-20 | $1.41 | $1.60 | $1.36 | $1.52 | 296 674 |
| 2023-01-19 | $1.44 | $1.45 | $1.39 | $1.44 | 55 312 |
| 2023-01-18 | $1.50 | $1.51 | $1.42 | $1.43 | 78 896 |
| 2023-01-17 | $1.43 | $1.53 | $1.35 | $1.47 | 304 549 |
| 2023-01-13 | $1.59 | $1.61 | $1.41 | $1.46 | 254 460 |
| 2023-01-12 | $1.62 | $1.71 | $1.52 | $1.56 | 480 800 |
| 2023-01-11 | $1.65 | $1.74 | $1.48 | $1.70 | 603 000 |
| 2023-01-10 | $1.58 | $1.66 | $1.55 | $1.61 | 237 518 |
| 2023-01-09 | $1.67 | $1.76 | $1.56 | $1.63 | 343 800 |
| 2023-01-06 | $1.75 | $1.75 | $1.46 | $1.57 | 200 900 |
| 2023-01-05 | $1.64 | $1.70 | $1.48 | $1.54 | 202 458 |
| 2023-01-04 | $1.67 | $1.73 | $1.57 | $1.63 | 190 061 |
| 2023-01-03 | $1.67 | $1.73 | $1.52 | $1.67 | 308 701 |
| 2022-12-30 | $1.56 | $1.66 | $1.45 | $1.64 | 329 632 |
| 2022-12-29 | $1.39 | $1.60 | $1.38 | $1.52 | 383 754 |
| 2022-12-28 | $1.47 | $1.58 | $1.41 | $1.43 | 139 705 |
| 2022-12-27 | $1.69 | $1.76 | $1.47 | $1.49 | 225 888 |
| 2022-12-23 | $1.60 | $1.73 | $1.60 | $1.70 | 58 942 |
| 2022-12-22 | $1.84 | $1.88 | $1.60 | $1.64 | 272 035 |
| 2022-12-21 | $1.83 | $1.89 | $1.83 | $1.84 | 28 881 |
| 2022-12-20 | $1.72 | $1.82 | $1.71 | $1.82 | 79 471 |
| 2022-12-19 | $2.01 | $2.09 | $1.75 | $1.77 | 185 599 |
| 2022-12-16 | $1.84 | $2.10 | $1.82 | $1.92 | 246 318 |
| 2022-12-15 | $1.76 | $1.85 | $1.70 | $1.81 | 203 291 |
| 2022-12-14 | $1.67 | $1.80 | $1.60 | $1.80 | 110 006 |
| 2022-12-13 | $1.82 | $1.82 | $1.60 | $1.65 | 152 867 |
| 2022-12-12 | $1.40 | $1.88 | $1.37 | $1.86 | 500 131 |
| 2022-12-09 | $1.42 | $1.44 | $1.36 | $1.37 | 82 394 |
| 2022-12-08 | $1.51 | $1.56 | $1.45 | $1.45 | 89 476 |
| 2022-12-07 | $1.55 | $1.64 | $1.50 | $1.53 | 85 991 |
| 2022-12-06 | $1.58 | $1.61 | $1.53 | $1.57 | 121 825 |
| 2022-12-05 | $1.58 | $1.63 | $1.57 | $1.60 | 51 846 |
| 2022-12-02 | $1.60 | $1.68 | $1.60 | $1.66 | 53 809 |
| 2022-12-01 | $1.67 | $1.69 | $1.56 | $1.65 | 88 928 |
| 2022-11-30 | $1.55 | $1.66 | $1.51 | $1.65 | 139 779 |
| 2022-11-29 | $1.65 | $1.65 | $1.54 | $1.56 | 164 091 |
| 2022-11-28 | $1.71 | $1.78 | $1.56 | $1.59 | 132 414 |
| 2022-11-25 | $1.70 | $1.77 | $1.69 | $1.70 | 64 595 |
| 2022-11-23 | $1.96 | $1.99 | $1.75 | $1.76 | 299 303 |
| 2022-11-22 | $1.53 | $1.95 | $1.53 | $1.95 | 558 965 |
About Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative ... BCLI Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
